Wednesday, December 12, 2018 2:19:34 PM
This is a PARTIAL cut & past of the article.
"I find it painfully ironic that the more fatal a disease is to the human body, the higher the valuation of the industry responsible for manufacturing and testing treatments to prevent said disease."
"Several years ago, the global market for cancer treatments hit $100 billion in annual sales, and at the time, analysts were projecting the industry to hit $150 billion by 2018, ****Some have gone as far as to call the cancer industry the most prosperous business in the United States. ****"
"One medical expert, Dr. Thomas N. Seyfried, Ph.D. posits that **“no real progress has been made in the management of advanced or metazoic cancer for more than 40 years”**"
"The name of the game in the cancer treatment industry is immuno-oncology or I-O. I-O is a new realm of cancer research where *leading experts and medical professionals* are looking to create treatment options that help the body’s own immune system to fight cancer. Think of your immune system as the main line of defense when you contract a disease. After first finding a foreign substance (germs, viruses, cancer cells) the immune system responds by trying to destroy the foreign cells."
"I find it painfully ironic that the more fatal a disease is to the human body, the higher the valuation of the industry responsible for manufacturing and testing treatments to prevent said disease."
"Several years ago, the global market for cancer treatments hit $100 billion in annual sales, and at the time, analysts were projecting the industry to hit $150 billion by 2018, ****Some have gone as far as to call the cancer industry the most prosperous business in the United States. ****"
"One medical expert, Dr. Thomas N. Seyfried, Ph.D. posits that **“no real progress has been made in the management of advanced or metazoic cancer for more than 40 years”**"
"The name of the game in the cancer treatment industry is immuno-oncology or I-O. I-O is a new realm of cancer research where *leading experts and medical professionals* are looking to create treatment options that help the body’s own immune system to fight cancer. Think of your immune system as the main line of defense when you contract a disease. After first finding a foreign substance (germs, viruses, cancer cells) the immune system responds by trying to destroy the foreign cells."
Recent CVM News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 12:03:20 PM
- CEL-SCI Reports Fiscal Second Quarter 2026 Results • Business Wire • 05/18/2026 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 09:00:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 09:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:44:06 PM
- CEL-SCI Announces Closing of Public Offering • Business Wire • 05/13/2026 07:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/12/2026 04:15:05 AM
- CEL-SCI Corporation Announces Pricing of Public Offering • Business Wire • 05/12/2026 12:11:00 AM
- CEL-SCI Enters Strategic Agreement with Amarox for the Registration, Commercialization, and Distribution of Multikine in Saudi Arabia • Business Wire • 05/11/2026 12:00:00 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/01/2026 09:00:54 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/17/2026 09:07:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 11:03:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 10:59:38 AM
- CEL-SCI Reports Fiscal First Quarter 2026 Results • Business Wire • 02/18/2026 02:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 10:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/26/2026 01:23:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:30:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:26:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2026 02:23:02 PM
- CEL-SCI Reports Fiscal 2025 Results • Business Wire • 12/29/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 01:48:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2025 10:00:37 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/07/2025 09:31:11 PM
